BC Innovations | Jun 22, 2017
Targets & Mechanisms

Exosomes deliver

Codiak BioSciences Inc. founder Raghu Kalluri has published the first animal data demonstrating exosomes can be used as drug delivery vehicles to treat cancer -- not just diagnose it. The findings also mark the unveiling...
BC Week In Review | May 20, 2002
Clinical News

CA19-9 radioimmunoassay regulatory update

The FDA granted marketing approval to Fujirebio's Fujirebio Diagnostics Inc. division (Malvern, Penn.) for its CA19-9 radioimmunoassay to monitor serum CA 19-9 levels in pancreatic cancer patients to assess treatment effectiveness. Fujirebio Inc. , Tokyo, Japan...
Items per page:
1 - 2 of 2